【ChiCTR2400093848】Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone
ChiCTR2400093848
结束
/
/
/
2024-12-12
/
/
Acne scar
Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone
Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone
41002
In this study, we propose to evaluate the effectiveness of a sequential combination of MNRF followed by FCO2 laser compared to each therapy alone in treating acne sc
随机平行对照
探索性研究/预试验
Random number table
None
University of Mosul
/
15
/
2022-10-01
2024-10-01
/
Forty-five patients suffering from various forms and severity of acne scars (box scar, ice pick scar, atrophic, and rolling atrophic scar).；
请登录查看Active acne lesions, hypertrophic and keloid scars, active herpes simplex, immunocompromised individuals, breast-feeding or pregnancy, recent isotretinoin use, coagulation issues, heart problems, and rejection of post-treatment evaluation were among the exclusion criteria.；
请登录查看University of Mosul
41002
University of Mosul的其他临床试验
- Fractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot Study
- Effectiveness and Safety of Topical Tofacitinib 2% Ointment versus Metronidazole 0.75% Cream in Erythematotelangiectatic Rosacea: A Randomized Controlled Trial.
- Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone
University of Mosul的其他临床试验
- Fractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot Study
- Effectiveness and Safety of Topical Tofacitinib 2% Ointment versus Metronidazole 0.75% Cream in Erythematotelangiectatic Rosacea: A Randomized Controlled Trial.
- Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29